← Back to headlines
Moderna Stock Jumps 15% on Positive Drug Pipeline Update
Moderna's stock surged by 15% as investors reacted positively to an update on the company's drug pipeline, fueling optimism about its future prospects.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
